Search research articles
Contact Us
Filters
Showing results (31-40 of 35) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 35 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm
Z Reguiai, J B Bachet, C Bachmeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
M Hebbar, B Chibaudel, T André, et al.
Plos One
|
December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer
L Mineur, E François, C Plassot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
M Hebbar, B Chibaudel, T André, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 35) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 35 results.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
April 28, 2012
Management of cutaneous adverse events induced by anti-EGFR (epidermal growth factor receptor): a French interdisciplinary therapeutic algorithm
Z Reguiai, J B Bachet, C Bachmeyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 23, 2015
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
M Hebbar, B Chibaudel, T André, et al.
Plos One
|
December 21, 2020
PREMIUM: A French prospective multicenter observational study of factors impacting on efficacy and compliance to cetuximab treatment in first-line KRAS wild-type metastatic colorectal cancer
L Mineur, E François, C Plassot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 30, 2017
Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer
D Azria, J Doyen, M Jarlier, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 19, 2014
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
M Hebbar, B Chibaudel, T André, et al.
Page
of 4